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Glucosamine sulfate (GS) and chondroitin sulfate (CS) are symptomatic slow-
acting drugs for osteoarthritis widely used in clinic, but with an unknown mechanism 
of action. The aim of this study is to evaluate the effects of both drugs GS and CS on 
cartilage cells (chondrocytes) to looking for cellular targets.
Chondrocytes obtained from healthy donors were treated with GS and CS, alone and 
in combination, and stimulated with IL-1β. Whole cell proteins were isolated 24 hours 
thereafter and resolved by 2-D electrophoresis. Gels were stained with SYPRORuby, 
and image analysis was performed using PDQuest software. Proteins of interest were 
identified by MALDI-TOF/TOF mass spectrometry. Real-time PCR and Western blot 
analyses were performed to validate our results.
We examined a mean of 500 protein spots that were present in each gel. Both 
qualitative and quantitative changes in protein expression patterns were studied. We 
identified 39 protein spots that were modulated by GS, 35 by CS and 48 by GS+CS 
compared to control (p<0.05). Database search showed that most of these proteins are 
involved in protein folding, stress response, cellular metabolism, protein targeting and 
oxidative stress. According to the essential role of oxidative stress balance that has been 
reported in osteoarthritis, we point out the effect of GS and CS (alone and combined) 
in counteracting the increase of mitochondrial superoxide dismutase that is caused by 
IL-1β.
In addition, the present study uses an in vitro model of inflammation (with IL-1β) 
to describe the effect of GS and CS on cartilage cells. We have identified several novel 
molecular targets of these compounds, such as SOD2, which may explain their reported 
good efficacy in osteoarthritis treatment. Our results highlight the synergic effect of 
the combined administration and point out the effectiveness of both molecules as anti-
inflammatory drugs.
